Author | Stephanie Lang, MD


Paclitaxel and UFT Plus Oral Calcium Folinate in Pretreated Metastatic Breast Cancer

July 01, 1999

ByUte Klaassen, MD|David Borquez, MD|Stephanie Lang, MD|Carsten Oberhoff, MD|Andreas Harstrick, MD|Siegfried Seeber, MD, PhD|Steven Benner, MD

This phase I study was designed to determine the maximum tolerated dose (MTD) and dose-limiting side effects of combination treatment with paclitaxel (Taxol) and UFT (uracil and tegafur in a 4:1 molar ratio) plus oral